ZNF681
gene geneOn this page
Also known as FLJ31526
Summary
ZNF681 (zinc finger protein 681, HGNC:26457) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 681 (Q96N22). May be involved in transcriptional regulation.
This gene encodes a protein containing the krueppel associated box (KRAB) and zinc-finger domains, which may be involved in transcriptional regulation. Non-functional alleles of this gene are present in alternate genome assemblies including T2T-CHM13v1.1, resulting from a ‘TG’ deletion (rs61397759) which causes a frameshift and a premature stop codon.
Source: NCBI Gene 148213 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 94 total
- MANE Select transcript:
NM_138286
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26457 |
| Approved symbol | ZNF681 |
| Name | zinc finger protein 681 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31526 |
| Ensembl gene | ENSG00000196172 |
| Ensembl biotype | protein_coding |
| Entrez | 148213 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000402377, ENST00000528059, ENST00000531570, ENST00000887419
RefSeq mRNA: 1 — MANE Select: NM_138286
NM_138286
CCDS: CCDS12414
Canonical transcript exons
ENST00000402377 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001949113 | 23739195 | 23745323 |
| ENSE00002246395 | 23755425 | 23755551 |
| ENSE00002278565 | 23758747 | 23758891 |
| ENSE00003590852 | 23754823 | 23754918 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 83.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.0464 / max 111.2585, expressed in 1127 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180281 | 3.4325 | 990 |
| 180280 | 1.6139 | 629 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.84 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.44 | gold quality |
| cortical plate | UBERON:0005343 | 78.97 | gold quality |
| ventricular zone | UBERON:0003053 | 78.44 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.00 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.46 | gold quality |
| calcaneal tendon | UBERON:0003701 | 71.79 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.59 | gold quality |
| upper leg skin | UBERON:0004262 | 68.75 | gold quality |
| rectum | UBERON:0001052 | 66.54 | gold quality |
| lymph node | UBERON:0000029 | 65.81 | gold quality |
| cerebellar cortex | UBERON:0002129 | 64.37 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 64.27 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.22 | gold quality |
| cerebellum | UBERON:0002037 | 63.56 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 63.31 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 63.22 | gold quality |
| bone marrow cell | CL:0002092 | 63.07 | silver quality |
| pancreas | UBERON:0001264 | 63.04 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 62.82 | gold quality |
| esophagus mucosa | UBERON:0002469 | 62.51 | gold quality |
| stromal cell of endometrium | CL:0002255 | 61.61 | gold quality |
| vermiform appendix | UBERON:0001154 | 61.52 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.10 | gold quality |
| tendon | UBERON:0000043 | 59.88 | gold quality |
| skin of hip | UBERON:0001554 | 59.86 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 59.73 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 59.70 | gold quality |
| tibia | UBERON:0000979 | 59.60 | silver quality |
| thymus | UBERON:0002370 | 59.60 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
216 targeting ZNF681, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp738 | ENSMUSG00000048280 |
| mus_musculus | Zfp457 | ENSMUSG00000055341 |
| mus_musculus | Zfp595 | ENSMUSG00000057842 |
| mus_musculus | Zfp953 | ENSMUSG00000098905 |
| rattus_norvegicus | AABR07009105.1 | ENSRNOG00000053325 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 681 — Q96N22 (reviewed: Q96N22)
All UniProt accessions (3): E9PJB6, E9PSC0, Q96N22
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96N22-1 | 1 | yes |
| Q96N22-2 | 2 |
RefSeq proteins (1): NP_612143* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050331 | Zinc_finger_PRDM4/PRDM1/PRDM14 | Family |
Pfam: PF00096, PF01352, PF13465
UniProt features (30 total): zinc finger region 16, sequence conflict 6, sequence variant 4, chain 1, domain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96N22-F1 | 66.83 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 71 (showing top):
MODULE_205, chr19p12, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, KIM_MYCN_AMPLIFICATION_TARGETS_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GTF2E2_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR548AJ_3P_MIR548X_3P, MIR335_3P, MIR548AE_3P_MIR548AQ_3P, MIR548AH_3P_MIR548AM_3P, MIR548J_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
282 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF681 | OR52N4 | Q8NGI2 | 540 |
| ZNF681 | SYNGR4 | O95473 | 471 |
| ZNF681 | TIGD7 | Q6NT04 | 471 |
| ZNF681 | TIGD6 | Q17RP2 | 446 |
| ZNF681 | ERVV-1 | B6SEH8 | 438 |
| ZNF681 | RGPD3 | A6NKT7 | 418 |
| ZNF681 | CRYBG2 | Q8N1P7 | 393 |
| ZNF681 | NKAPL | Q5M9Q1 | 375 |
| ZNF681 | CGAS | Q8N884 | 348 |
| ZNF681 | KLK9 | Q9UKQ9 | 348 |
| ZNF681 | RAB36 | O95755 | 307 |
| ZNF681 | VEZT | Q9HBM0 | 291 |
| ZNF681 | ABCC12 | Q96J65 | 289 |
| ZNF681 | KLK12 | Q9UKR0 | 277 |
| ZNF681 | ACTB | P02570 | 277 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ECE1 | ZNF681 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (1): ZNF681 (Affinity Capture-MS)
ESM2 similar proteins: A6NK75, A6NNF4, A6NP11, A8MTY0, B4DXR9, C9JN71, O75346, O75373, O75437, O95780, P0CJ79, P0DKX0, P0DPD5, P17017, P17019, P17035, P17038, P35789, Q03923, Q03924, Q03936, Q03938, Q08AN1, Q5MCW4, Q5R9F0, Q5SXM1, Q68DY1, Q6JLC9, Q6P5C7, Q6ZMV8, Q6ZN06, Q6ZN08, Q6ZNA1, Q6ZNG1, Q76KX8, Q86V71, Q86XN6, Q8IYB9, Q8IYN0, Q8N4W9
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
94 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 83 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
834 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:23745321:TAA:T | acceptor_gain | 0.9900 |
| 19:23745324:C:CC | acceptor_gain | 0.9900 |
| 19:23758742:CTCA:C | donor_loss | 0.9900 |
| 19:23758743:TCAC:T | donor_loss | 0.9900 |
| 19:23758744:CA:C | donor_loss | 0.9900 |
| 19:23758745:ACCAT:A | donor_loss | 0.9900 |
| 19:23758746:C:A | donor_loss | 0.9900 |
| 19:23745320:ATAA:A | acceptor_gain | 0.9800 |
| 19:23754927:T:TC | acceptor_gain | 0.9800 |
| 19:23758741:TCTCA:T | donor_loss | 0.9800 |
| 19:23745319:AATAA:A | acceptor_gain | 0.9700 |
| 19:23754817:ACCT:A | donor_loss | 0.9700 |
| 19:23754818:CCTA:C | donor_loss | 0.9700 |
| 19:23754819:CTA:C | donor_loss | 0.9700 |
| 19:23754820:TA:T | donor_loss | 0.9700 |
| 19:23754821:ACC:A | donor_loss | 0.9700 |
| 19:23754822:C:CG | donor_loss | 0.9700 |
| 19:23754903:T:C | acceptor_gain | 0.9700 |
| 19:23745213:A:C | donor_gain | 0.9500 |
| 19:23755464:T:A | donor_gain | 0.9500 |
| 19:23758745:A:AC | donor_gain | 0.9500 |
| 19:23758746:C:CC | donor_gain | 0.9500 |
| 19:23758780:G:C | donor_gain | 0.9500 |
| 19:23745322:AAC:A | acceptor_loss | 0.9400 |
| 19:23745323:ACTG:A | acceptor_loss | 0.9400 |
| 19:23745324:CTGAA:C | acceptor_loss | 0.9400 |
| 19:23754915:ATACC:A | acceptor_loss | 0.9400 |
| 19:23754916:TACCT:T | acceptor_loss | 0.9400 |
| 19:23754917:AC:A | acceptor_loss | 0.9400 |
| 19:23754918:CC:C | acceptor_loss | 0.9400 |
AlphaMissense
4313 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:23743837:A:C | F571L | 0.983 |
| 19:23743837:A:T | F571L | 0.983 |
| 19:23743839:A:G | F571L | 0.983 |
| 19:23743753:A:C | F599L | 0.973 |
| 19:23743753:A:T | F599L | 0.973 |
| 19:23743755:A:G | F599L | 0.973 |
| 19:23743921:A:C | F543L | 0.973 |
| 19:23743921:A:T | F543L | 0.973 |
| 19:23743923:A:G | F543L | 0.973 |
| 19:23744425:A:C | F375L | 0.973 |
| 19:23744425:A:T | F375L | 0.973 |
| 19:23744427:A:G | F375L | 0.973 |
| 19:23744509:A:C | F347L | 0.970 |
| 19:23744509:A:T | F347L | 0.970 |
| 19:23744511:A:G | F347L | 0.970 |
| 19:23744089:A:C | F487L | 0.966 |
| 19:23744089:A:T | F487L | 0.966 |
| 19:23744091:A:G | F487L | 0.966 |
| 19:23744005:G:C | F515L | 0.956 |
| 19:23744005:G:T | F515L | 0.956 |
| 19:23744007:A:G | F515L | 0.956 |
| 19:23743832:T:G | Q573P | 0.953 |
| 19:23744341:A:C | F403L | 0.953 |
| 19:23744341:A:T | F403L | 0.953 |
| 19:23744343:A:G | F403L | 0.953 |
| 19:23755516:G:C | F13L | 0.951 |
| 19:23755516:G:T | F13L | 0.951 |
| 19:23755518:A:G | F13L | 0.951 |
| 19:23744173:A:C | F459L | 0.950 |
| 19:23744173:A:T | F459L | 0.950 |
dbSNP variants (sampled 300 via entrez): RS1000055536 (19:23743283 C>T), RS1000160105 (19:23747279 A>T), RS1000191898 (19:23752338 C>A), RS1000250786 (19:23751671 T>C), RS1000331581 (19:23758561 G>A), RS1000586136 (19:23739275 A>G), RS1000849273 (19:23758071 G>A,T), RS1001130016 (19:23752502 A>G), RS1001420784 (19:23758244 A>G), RS1002143265 (19:23758687 G>A,C), RS1002163224 (19:23743932 C>T), RS1002195554 (19:23758861 G>A,C,T), RS1002224931 (19:23748951 C>CAA), RS1002336118 (19:23756077 G>T), RS1002446725 (19:23744983 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 2 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| titanium dioxide | decreases expression | 1 |
| hydroxyhydroquinone | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Rosiglitazone | decreases reaction, increases expression | 1 |
| Pioglitazone | decreases reaction, increases expression | 1 |
| Troglitazone | decreases reaction, increases expression | 1 |
| Hydrogen Peroxide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| tert-Butylhydroperoxide | decreases reaction, increases expression | 1 |
| Magnetite Nanoparticles | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.